Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 68788-7526

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 68788-7526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Triamterene Chemical Structure (Image 1)

FDA Label Image

Hydrochlorothiazide Chemical Structure (Image 2)

FDA Label Image

Triamterene And Hctz Capsultes 37.5mg/25mg (Image 3)

Triamterene And Hctz Capsultes 37.5mg/25mg (Image 3)
This is a medication for hypertension and edema, and is a generic version of Maxzide. Each tablet contains Hydrochlorothiazide USP 25mg and Tramterene USP 37.5mg. The recommended dosage should be used as directed by a doctor with a caution prohibiting the transfer of this medication to any person other than the patient it was prescribed. There is also information in Spanish. A prod number and insurance NDC number are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.